133 related articles for article (PubMed ID: 33857857)
1. DNA methylation and protein expression of Wnt pathway markers in progressive glioblastoma.
Tompa M; Kajtar B; Galik B; Gyenesei A; Kalman B
Pathol Res Pract; 2021 Jun; 222():153429. PubMed ID: 33857857
[TBL] [Abstract][Full Text] [Related]
2. Wnt pathway markers in molecular subgroups of glioblastoma.
Tompa M; Nagy A; Komoly S; Kalman B
Brain Res; 2019 Sep; 1718():114-125. PubMed ID: 31075260
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the Catecholamine Pathway in Glioblastoma Development.
Kraboth Z; Kajtár B; Gálik B; Gyenesei A; Miseta A; Kalman B
Cells; 2021 Mar; 10(3):. PubMed ID: 33806345
[TBL] [Abstract][Full Text] [Related]
4. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
5. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
[TBL] [Abstract][Full Text] [Related]
6. GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling.
Matias D; Dubois LG; Pontes B; Rosário L; Ferrer VP; Balça-Silva J; Fonseca ACC; Macharia LW; Romão L; E Spohr TCLS; Chimelli L; Filho PN; Lopes MC; Abreu JG; Lima FRS; Moura-Neto V
Mol Neurobiol; 2019 Feb; 56(2):1517-1530. PubMed ID: 29948952
[TBL] [Abstract][Full Text] [Related]
7. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
[TBL] [Abstract][Full Text] [Related]
8. Regulatory role of miRNAs on Wnt/β-catenin signaling in tumorigenesis of glioblastoma.
Rahmani F; Hashemian P; Tabrizi AT; Ghorbani Z; Ziaeemehr A; Alijannejad S; Ferns GA; Avan A; Shahidsales S
Indian J Cancer; 2023; 60(3):295-302. PubMed ID: 37787188
[TBL] [Abstract][Full Text] [Related]
9. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
Lan F; Pan Q; Yu H; Yue X
J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
[TBL] [Abstract][Full Text] [Related]
11. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
[TBL] [Abstract][Full Text] [Related]
12. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/β-catenin pathway.
Wang J; Xia X; Tao X; Zhao P; Deng C
Bioengineered; 2021 Dec; 12(1):3934-3946. PubMed ID: 34288811
[TBL] [Abstract][Full Text] [Related]
14. ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling.
Chen X; Huang L; Yang Y; Chen S; Sun J; Ma C; Xie J; Song Y; Yang J
Aging (Albany NY); 2020 Jan; 12(1):224-241. PubMed ID: 31905171
[TBL] [Abstract][Full Text] [Related]
15. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
16. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
17. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
[TBL] [Abstract][Full Text] [Related]
19. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation in glioblastoma: impact on gene expression and clinical outcome.
Etcheverry A; Aubry M; de Tayrac M; Vauleon E; Boniface R; Guenot F; Saikali S; Hamlat A; Riffaud L; Menei P; Quillien V; Mosser J
BMC Genomics; 2010 Dec; 11():701. PubMed ID: 21156036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
